Evidence map›Paper›PMID 39174853›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2024

A Novel Compound Heterozygous Mutation in TDRD9 Causes Oligozoospermia.

Wenhua Wang, Yuming Feng, Jie Dong, Zheng Zhou, Jun Jing, Zixiong Li, Li Chen, Xiaoqi Lin, Jinzhao Ma, Bing Yao

Registry-linked trialAbstract readCase Reports
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07402759 (Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07402759 phase3active not recruitingnot on this mapstarted 2026, after this paper: background citation

Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men

TypeinterventionalSponsorSouth Valley UniversityRan2026 to 2026Enrolled50ConditionsOligoasthenozoospermia, Male InfertilityArmsL-carnitine
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wenhua Wang *Center of Reproductive Medicine, Affiliated Jinling Hospital, Nanjing Medical University, Nanjing, 210002, Jiangsu, China.
Yuming Feng *Center of Reproductive Medicine, Clinical School of Medical College, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, Jiangsu, China.
Jie Dong *Center of Reproductive Medicine, Clinical School of Medical College, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, Jiangsu, China.
Zheng ZhouCenter of Reproductive Medicine, Clinical School of Medical College, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, Jiangsu, China.
Jun JingCenter of Reproductive Medicine, Affiliated Jinling Hospital, Nanjing Medical University, Nanjing, 210002, Jiangsu, China.
Zixiong LiDepartment of Oncology, Nanjing Jinling Hospital of Nanjing University, Nanjing, 210002, China.
Li ChenCenter of Reproductive Medicine, Affiliated Jinling Hospital, Nanjing Medical University, Nanjing, 210002, Jiangsu, China.
Xiaoqi LinCenter of Reproductive Medicine, Clinical School of Medical College, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, Jiangsu, China.
Jinzhao MaCenter of Reproductive Medicine, Affiliated Jinling Hospital, Nanjing Medical University, Nanjing, 210002, Jiangsu, China. majinzhao07@163.com.
Bing YaoCenter of Reproductive Medicine, Affiliated Jinling Hospital, Nanjing Medical University, Nanjing, 210002, Jiangsu, China. yaobing@nju.edu.cn.ORCID 0000-0002-5598-9704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oligozoospermia is an important cause of male infertility for which treatment options are limited. Spermatogenesis is complex, and the causes of oligozoospermia remain largely unknown. Because genetic mutations are important factors of oligozoospermia pathogenesis, our study aimed to explore the genetic causes of oligozoospermia. Whole- exome sequencing (WES) was performed on one proband from a Chinese family who was diagnosed with oligozoospermia. The pathogenic mutations were confirmed by Sanger sequencing, and a minigene assay was used to determine the effect of the identified splicing mutation. We identified a novel compound heterozygous mutation in the TDRD9 gene, comprising a splicing mutation (c.1115 + 3A > G) and a frameshift mutation (c.958delC), in the proband; neither of these mutations were found in 50 unrelated healthy people. In addition, a minigene assay demonstrated that the frameshift produced partially truncated protein, and the splicing mutation led to a frameshift mutation and premature termination due to abnormal alternative splicing of TDRD9. These findings indicate that deleterious compound heterozygous mutation in TDRD9 could lead to oligozoospermia, highlighting the crucial role of TDRD9 in spermatogenesis and further clarifying the genetic causes of male infertility resulting from oligozoospermia. Our study expands the spectrum of TDRD9-related phenotypes and provides a new specific target for future genetic counseling.

Indexed as

DNA HelicasesOligospermiaAdultExome SequencingFrameshift MutationGenetic Predisposition to DiseaseHeterozygoteHumansMaleMutationPedigreeDNA HelicasesTDRD9 protein, humanCompound heterozygous mutationMale infertilityOligozoospermiaTDRD9

Identifiers

PMID39174853
PMCPMC11527903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.